A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations

J Virol Methods. 2007 Nov;145(2):137-45. doi: 10.1016/j.jviromet.2007.05.016. Epub 2007 Jun 29.

Abstract

Hepatitis C virus (HCV) replicon-based shuttle vectors that permit phenotypes of NS5B polymerase genes from a large number of patient isolates to be rapidly assessed when transiently expressed in cultured cells were designed. When used to test responses to an inhibitor of HCV RNA-dependent RNA polymerase, IC(50) values for inhibition covered a several hundred-fold range among 47 patient samples tested. This observation highlights the variability that can be found by testing isolates derived from HCV-infected subjects. Partial suppression with a polymerase inhibitor of the most sensitive species permitted detection of minor quasispecies that were 7-200-fold more resistant than the bulk population in approximately half of the samples. Sequence analysis showed a wide range of amino acid changes not detected by conventional selection methods using laboratory-derived strains. This approach provides a means to assess variation in antiviral efficacy, and to predict possible responses in a clinical setting.

MeSH terms

  • Antiviral Agents / pharmacology
  • Drug Resistance, Viral
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Viral
  • Genetic Vectors*
  • Genotype
  • Hepacivirus / drug effects
  • Hepacivirus / enzymology
  • Hepacivirus / genetics*
  • Hepacivirus / isolation & purification
  • Hepatitis C / virology*
  • Humans
  • Phenotype
  • Plasmids
  • RNA, Viral / isolation & purification
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • RNA-Dependent RNA Polymerase / genetics*
  • RNA-Dependent RNA Polymerase / isolation & purification
  • Replicon*
  • Viral Nonstructural Proteins / antagonists & inhibitors
  • Viral Nonstructural Proteins / genetics*
  • Viral Nonstructural Proteins / isolation & purification

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • RNA, Viral
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus
  • RNA-Dependent RNA Polymerase